Skip to main content

Top Research Publications: September 2023

Top Research Publications of September

Note: Names in bold are faculty members in the Department of Internal Medicine.

Epidemiology

  1. Vanneman ME, Samore MH, Zheng T, Pettey WBP, Fagerlin A, Harris AHS. Choosing Veterans Affairs: Determinants of post-9/11 Veterans' enrollment in Veterans Affairs health care. Medicine (Baltimore). Aug 18 2023;102(33):e34814. doi:10.1097/md.0000000000034814
  2. Naranjo D, Kimball E, Nelson J, Samore M, Alder SC, Stroupe K, Evans CT, Weaver FM, Ray C, Kale I, Galyean PO, Zickmund S. Differences in perceptions and acceptance of COVID-19 vaccination between vaccine hesitant and non-hesitant persons. PLoS One. 2023;18(9):e0290540. doi:10.1371/journal.pone.0290540
  3. Classen DC, Longhurst CA, Davis T, Milstein JA, Bates DW. Inpatient EHR User Experience and Hospital EHR Safety Performance. JAMA Netw Open. Sep 5 2023;6(9):e2333152. doi:10.1001/jamanetworkopen.2023.33152

Gastroenterology, Hepatology & Nutrition

  1. Hirano I, Dellon ES, Falk GW, Gonsalves NP, Furuta GT, Bredenoord AJ; Assessment of Clinical endpoints in Eosinophilic esophagitis for Novel Therapeutics (ASCENT) working group; Straumann A, Alain S, Chang JW, Peterson K, Talley NJ, von Arnim U, Savarino EV, Christoph S, Wershil BK, Menard-Katcher C, Muir AB, Wechsler JB, Chehade M, Spergel JM, Atkins D, Oliva S, Arva NC, Guang-Yu Y, Jensen ET, Safroneeva E, Ackerman S, Gupta SK, Rothenberg M, Katzka D, Pletneva M, Wright BL, Hiremath G, Klion A, Attwood S, Bonis P, Aceves S, Ghisa M, Miehlke S, Vanuytsel T, Woodland P, Thomas G, Kuang FL. Ascending to new heights for novel therapeutics for eosinophilic esophagitis. Gastroenterology. 2023 Sep 8:S0016-5085(23)04979-X. doi: 10.1053/j.gastro.2023.09.004. Online ahead of print. PMID: 37690772
  2. Uchida AM, Burk CM, Rothenberg ME, Furuta GT, Spergel JM. Recent Advances in the Treatment of Eosinophilic Esophagitis. J Allergy Clin Immunol Pract. 2023 Sep;11(9):2654-2663. doi: 10.1016/j.jaip.2023.06.035. Epub 2023 Jun 28. PMID: 37391018
  3. Gawron AJ, Horner B, Zurbuchen R, Boynton K, Fang JC. A comprehensive intervention to enhance inpatient colon preparation quality for colonoscopy. Minerva Gastroenterol (Torino). 2023 Sep;69(3):351-358. doi: 10.23736/S2724-5985.21.02766-5. Epub 2021 Apr 1.PMID: 33793164+

General internal Medicine

  1. Lee Cervi A, Applegate D, Stevens SM, Woller SC, Baumann Kreuziger LM, Punchhalapalli K, Wang TF, Lecumberri R, Greco K, Bai Y, Bolger S, Fontyn S, Schulman S, Foster G, Douketis JD. Antithrombotic Management of Patients with Deep Vein Thrombosis and Venous Stents: An International Registry. J Thromb Haemost. 2023 Sep 20:S1538-7836(23)00707-9. doi: 10.1016/j.jtha.2023.09.008. Epub ahead of print. PMID: 37739038.
  2. Drum B, Shi J, Peterson B, Lamb S, Hurdle JF, Gradick C. Using Natural Language Processing and Machine Learning to Identify Internal Medicine-Pediatrics Residency Values in Applications. Acad Med. 2023 Jul 27. doi: 10.1097/ACM.0000000000005352. Epub ahead of print. PMID: 37506388.

Hematology

  1. Denorme F, Andrianova I, Cody MJ, Kosaka Y, Campbell RA. Age Specific Impact of Type I Interferons on Cerebral Thrombosis and Inflammation. Blood Advances. 2023 Sep 22. 2023010495. doi: 10.1182/bloodadvances.2023010495. Epub ahead of print. PMID: 37738163.
  2. Dobish KK, Wittorf KJ, Swenson SA, Bean DC, Gavile CM, Woods NT, Ghosal G,

Hyde RK, Buckley SM. FBXO21 mediated degradation of p85α regulates proliferation and survival of acute myeloid leukemia. Leukemia. 2023 Sep 9. doi:10.1038/s41375-023-02020-w. Epub ahead of print. PMID: 37689825

  1. Voorhees PM, Sborov DW, Laubach J, Kaufman JL, Reeves B, Rodriguez C, Chari A, Silbermann R, Costa LJ, Anderson LD Jr, Nathwani N, Shah N, Bumma N, Efebera YA, Holstein SA, Costello C, Jakubowiak A, Wildes TM, Orlowski RZ, Shain KH, Cowan AJ, Dinner S, Pei H, Cortoos A, Patel S, Lin TS, Usmani SZ, Richardson PG. Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial. Lancet Hematology. 2023 Sep 11:S2352-3026(23)00217-X. doi: 10.1016/S2352-3026(23)00217-X. Epub ahead of print. PMID: 37708911.

Infectious Disease

  1. Pender M, Throneberry SK, Grisel N, Leung DT, Lopansri BK.  Syndromic Panel Testing Among Patients With Infectious Diarrhea: The Challenge of Interpreting Clostridioides difficile Positivity on a Multiplex Molecular Panel. Open Forum Infect Dis. 2023 Apr 10;10(5): ofad184. doi: 10.1093/ofid/ofad184. PMID: 37711280 PM
  2. Reiersen Angela M, Mattar Caline, Bender Ignacio Rachel A, Boulware David R, Lee Todd C, Hess Rachel, Lankowski Alexander J, McDonald Emily G, Miller J Philip, Powderly William G, Pullen Matthew F, Radao Jeffrey T, Rich Michael W, Schiffer Joshua T, Schweiger Julie, Spivak Adam M, Stevens Angela, Vigod Simone N, Agarwal Payal, Yang Lei, Yingling Michael, Gettinger Torie R, Zorumski Charles F, Lenze Eric J. The STOP COVID 2 Study: Fluvoxamine vs Placebod for Outpatients with Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial Open Forum Infect Dis. 2023 Aug 8; 10(8): ofad419. Doi: 10.1093/ofid/ofad491. PMID: 37622035 PMCID: PMC10445518 DOI: 10.1093/ofid/ofad419

Oncology

  1. Sayegh N, Swami U, Jo Y, Gebrael G, Haaland B, Gupta S, Plets M, Hussain MHA, Quinn DI, Lara PN Jr, Thompson IM Jr, Agarwal N.  Race and Treatment Outcomes in Patients With Metastatic Castration-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG 1216 Phase 3 Trial. JAMA Netw Open. 2023 Aug 1;6(8):e2326546. doi: 10.1001/jamanetworkopen.2023.26546.PMID: 37526936 
  2. Beatty GL, Delman D, Yu J, Liu M, Li JH, Zhang L, Lee JW, Chang RB, Bahary N, Kennedy EP, Wang-Gillam A, Rossi GR, Garrido-Laguna I. Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration. Clin Cancer Res. 2023 Sep 1;29(17):3514-3525. doi: 10.1158/1078-0432.CCR-23-0535.PMID: 37534996
  3. Florou V, Floudas CS, Maoz A, Naqash AR, Norton C, Tan AC, Sokol ES, Frampton G, Soares HPPuri SSwami U, Wilky B, Hosein P, Trent J, Lopes GL, Park W, Garrido-Laguna I. Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden. J Immunother Cancer. 2023 Aug;11(8):e007440. doi: 10.1136/jitc-2023-007440.PMID: 37586768

Rheumatology

  1. Battistone MJ, Kemeyou L, Varpio L. The Theoretical Integrative Review-A Reader's Guide. J Grad Med Educ. 2023 Aug;15(4):449-452. doi: 10.4300/JGME-D-23-00265.1. PMID: 37637333; PMCID: PMC10449344.
  2. Schlesinger N, Patel A, Rustgi VK, Yeo AE, Lipsky PE. Increased frequency of hepatic steatosis and fibrosis in patients with gout detected by transient elastography. Clin Exp Rheumatol. 2023 Jul 24. Online ahead of print. PMID: 37497724.
  3. Walsh JA, Carroll C, Callis Duffin K, Wang J, Krueger GG, Feng BJ. PAPRIKA: A Question Bank for Assessing Psoriatic Arthritis Risk in Individuals of Diverse Ancestries. Arthritis Care Res (Hoboken). 2023 Sep 10. doi: 10.1002/acr.25232. Online ahead of print. PMID: 37691268.